Status:
COMPLETED
Topical Vancomycin in Prevention of Methicillin-Resistant Staphylococcal Related Mediastinitis in Patients Receiving Coronary Artery Bypass Graft
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Sternal or mediastinal infections after heart operation occurs infrequently but carries a high cost in money, morbidity, and mortality. At our hospital, Staphylococcus species cause most of these infe...
Detailed Description
Background Postoperative sterno-mediastinitis is a life-threatening complication. Although the incidence rate is about 0.75 to 1.4% in all open heart operations, the association with morbidity, mortal...
Eligibility Criteria
Inclusion
- Patients with coronary artery disease underwent aoronary artery bypass grafting
Exclusion
- Patients who ever received vancomycin or teicoplanin or linezolids within one week will be excluded. Other exclusion criteria are patients in pregnant, allergic to vancomycin, and hesitate to this study plan.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00711685
Start Date
January 1 2007
Last Update
July 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
Taipei, Taiwan